Population Bio Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Population Bio General Information

Description

Developer of gene discovery platform designed to help pharmaceutical companies accelerate drug discovery. The company's platform rationally interprets the vast spectrum of variation in human genomes to uncover the genetic components of complex diseases such as Autism, Parkinson's, Alzheimer's and Diabetes, enabling healthcare companies to develop targeted therapies and companion diagnostics in a cost-effective manner.

Contact Information

Formerly Known As
Population Diagnostics
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1120 Avenue of the Americas
  • Suite 1514
  • Melville, NY 10036
  • United States
+1 (212)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Drug Delivery
Vertical(s)
Corporate Office
  • 1120 Avenue of the Americas
  • Suite 1514
  • Melville, NY 10036
  • United States
+1 (212)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Population Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Apr-2023 Completed Generating Revenue
4. Later Stage VC 01-Oct-2015 Completed Generating Revenue
3. Later Stage VC 30-May-2014 Completed Generating Revenue
2. Later Stage VC (Series A) 29-Aug-2011 $5.36M $5.36M Completed Generating Revenue
1. Grant 17-May-2010 $489K Completed Generating Revenue
To view Population Bio’s complete valuation and funding history, request access »

Population Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Population Bio’s complete cap table history, request access »

Population Bio Patents

Population Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240310389-A1 Methods and compositions for screening and treating alzheimer's disease Pending 12-Jan-2023
US-10724096-B2 Methods and compositions for inhibiting and treating neurological conditions Active 05-Sep-2014
GB-2558326-B Methods and compositions for inhibiting and treating neurological conditions Active 05-Sep-2014
GB-2558326-A Methods and compositions for inhibiting and treating neurological conditions Active 05-Sep-2014
GB-201705081-D0 Methods and compositions for inhibiting and treating neurological conditions Active 05-Sep-2014 C12Q1/6883
To view Population Bio’s complete patent history, request access »

Population Bio Executive Team (4)

Name Title Board Seat
Jim Chinitz Co-Founder, Chairman, Chief Executive Officer and President
Peggy Eis Ph.D Co-Founder, Chief Technology Officer & Board Member
Eli Hatchwell MD Co-Founder & Chief Scientific Officer
Edward Smith III Executive Chairman
To view Population Bio’s complete executive team members history, request access »

Population Bio Board Members (7)

Name Representing Role Since
Amina Abrahams Self Board Member
Edward Smith III Population Bio Executive Chairman
Jim Chinitz Population Bio Co-Founder, Chairman, Chief Executive Officer and President
Josiah Hornblower Self Board Member
Naval Khera Self Board Member
You’re viewing 5 of 7 board members. Get the full list »

Population Bio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Five Stones Investment Group Hedge Fund Minority
Hunter Trust Family Office Minority
National institutes of Neurological Disorders and Stroke Government
U.S. Department of Health and Human Services Government
To view Population Bio’s complete investors history, request access »

Population Bio FAQs

  • When was Population Bio founded?

    Population Bio was founded in 2006.

  • Who is the founder of Population Bio?

    Jim Chinitz, Peggy Eis Ph.D, and Eli Hatchwell MD are the founders of Population Bio.

  • Who is the CEO of Population Bio?

    Jim Chinitz is the CEO of Population Bio.

  • Where is Population Bio headquartered?

    Population Bio is headquartered in Melville, NY.

  • What industry is Population Bio in?

    Population Bio’s primary industry is Discovery Tools (Healthcare).

  • Is Population Bio a private or public company?

    Population Bio is a Private company.

  • What is Population Bio’s current revenue?

    The current revenue for Population Bio is .

  • How much funding has Population Bio raised over time?

    Population Bio has raised $5.36M.

  • Who are Population Bio’s investors?

    Five Stones Investment Group, Hunter Trust, National institutes of Neurological Disorders and Stroke, and U.S. Department of Health and Human Services have invested in Population Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »